Literature DB >> 10944105

Crystal structure of the matrix protein VP40 from Ebola virus.

A Dessen1, V Volchkov, O Dolnik, H D Klenk, W Weissenhorn.   

Abstract

Ebola virus maturation occurs at the plasma membrane of infected cells and involves the clustering of the viral matrix protein VP40 at the assembly site as well as its interaction with the lipid bilayer. Here we report the X-ray crystal structure of VP40 from Ebola virus at 2.0 A resolution. The crystal structure reveals that Ebola virus VP40 is topologically distinct from all other known viral matrix proteins, consisting of two domains with unique folds, connected by a flexible linker. The C-terminal domain, which is absolutely required for membrane binding, contains large hydrophobic patches that may be involved in the interaction with lipid bilayers. Likewise, a highly basic region is shared between the two domains. The crystal structure reveals how the molecule may be able to switch from a monomeric conformation to a hexameric form, as observed in vitro. Its implications for the assembly process are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10944105      PMCID: PMC302032          DOI: 10.1093/emboj/19.16.4228

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  59 in total

1.  Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.

Authors:  A Nicholls; K A Sharp; B Honig
Journal:  Proteins       Date:  1991

2.  Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain.

Authors:  W Weissenhorn; A Carfí; K H Lee; J J Skehel; D C Wiley
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

Review 3.  Classification, structure, and replication of filoviruses.

Authors:  H Feldmann; M P Kiley
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

Review 4.  Marburg and Ebola viruses.

Authors:  H Feldmann; H D Klenk
Journal:  Adv Virus Res       Date:  1996       Impact factor: 9.937

5.  [On the etiology of an unknown human infection originating from monkeys].

Authors:  R Siegert; H L Shu; W Slenczka; D Peters; G Müller
Journal:  Dtsch Med Wochenschr       Date:  1967-12-22       Impact factor: 0.628

6.  Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1.

Authors:  B Sha; M Luo
Journal:  Nat Struct Biol       Date:  1997-03

7.  Direct interaction between the envelope and matrix proteins of HIV-1.

Authors:  P Cosson
Journal:  EMBO J       Date:  1996-11-01       Impact factor: 11.598

8.  Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms.

Authors:  M Yeager; E M Wilson-Kubalek; S G Weiner; P O Brown; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

9.  Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly.

Authors:  C P Hill; D Worthylake; D P Bancroft; A M Christensen; W I Sundquist
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

10.  The three-dimensional solution structure of the matrix protein from the type D retrovirus, the Mason-Pfizer monkey virus, and implications for the morphology of retroviral assembly.

Authors:  M R Conte; M Klikova; E Hunter; T Ruml; S Matthews
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

View more
  74 in total

1.  Membrane association induces a conformational change in the Ebola virus matrix protein.

Authors:  S Scianimanico; G Schoehn; J Timmins; R H Ruigrok; H D Klenk; W Weissenhorn
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

2.  Ebola virus VP40-induced particle formation and association with the lipid bilayer.

Authors:  L D Jasenosky; G Neumann; I Lukashevich; Y Kawaoka
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding.

Authors:  Ziying Han; Hani Boshra; J Oriol Sunyer; Susan H Zwiers; Jason Paragas; Ronald N Harty
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

4.  Viral and host proteins that modulate filovirus budding.

Authors:  Yuliang Liu; Ronald N Harty
Journal:  Future Virol       Date:  2010-07-01       Impact factor: 1.831

5.  Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription.

Authors:  T Hoenen; N Biedenkopf; F Zielecki; S Jung; A Groseth; H Feldmann; S Becker
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

Review 6.  Conformational plasticity of the Ebola virus matrix protein.

Authors:  Jens Radzimanowski; Gregory Effantin; Winfried Weissenhorn
Journal:  Protein Sci       Date:  2014-09-04       Impact factor: 6.725

7.  Key genomic changes necessary for an in vivo lethal mouse marburgvirus variant selection process.

Authors:  Loreen L Lofts; Jay B Wells; Sina Bavari; Kelly L Warfield
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

8.  Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transport.

Authors:  Seiya Yamayoshi; Takeshi Noda; Hideki Ebihara; Hideo Goto; Yuko Morikawa; Igor S Lukashevich; Gabriele Neumann; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  Cell Host Microbe       Date:  2008-03-13       Impact factor: 21.023

9.  Could the Ebola virus matrix protein VP40 be a drug target?

Authors:  Robert V Stahelin
Journal:  Expert Opin Ther Targets       Date:  2013-11-28       Impact factor: 6.902

10.  Crystal structure of the Borna disease virus matrix protein (BDV-M) reveals ssRNA binding properties.

Authors:  Piotr Neumann; Diana Lieber; Sylke Meyer; Philipp Dautel; Andreas Kerth; Ina Kraus; Wolfgang Garten; Milton T Stubbs
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.